007 gegen HIV 🎯🔬 Ein neuer Antikörper, entwickelt von einem internationalen Forschungsteam um Prof. Dr. Florian Klein an der #UniKöln und Uniklinik Köln, zeigt vielversprechende Potenzial für die Bekämpfung von HIV-1. Mehr dazu 👇 uni.koeln/WEAFH

007 against HIV 🎯🔬 A new antibody, developed by an international research team led by Prof. Dr. Florian Klein at the #UniCologne, shows promising potential in fighting HIV-1. Antibody 007 targets a key vulnerability of the virus – the V3 glycan site – in a way previously unseen👇 uni.koeln/3BQJY

📢 ISCO registration is now open for registration! Everyone interested in the latest developments in single-cell approaches and their applications will enjoy our exciting lineup of speakers. 🌞 Join us in sunny Barcelona this May!

We report two cases of severe CIDP following cilta-cel therapy. Findings suggest bystander activation of CD8⁺ non-CAR-T cells rather than direct CAR-T toxicity. Timely T-cell–depleting therapy with cyclophosphamide may improve outcomes. Out now in the Blood Cancer Journal!